<DOC>
	<DOCNO>NCT01287338</DOCNO>
	<brief_summary>The purpose study test olopatadine punctal plug reduce symptom ( itch ) allergic conjunctivitis ragweed Environmental Exposure Chamber model .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy QLT Proprietary Olopatadine-PPDS Subjects With Seasonal Allergic Conjunctivitis Ragweed Environmental Exposure Chamber Model .</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>History allergic conjunctivitis ragweed least one year Positive skin prick test ragweed pollen within 12 month prior visit 1 BCVA leat 20/400 Structural lid abnormality ( ectropion , entropion ) Active lid disease ( ie moderate severe blepharitis , meibomianitis ) require medical treatment Presence follicular conjunctivitis , anterior uveitis preauricular lymphadenopathy History ophthalmic abnormality , include history dry eye Perennial allergic rhinoconjunctivitis significant allergy animal dander avoid study period History chronic bacterial viral ocular infection , herpes keratitis , and/or presence active bacterial viral ocular infection presence mucous discharge , excess lacrimation burning symptom ocular disease Currently chronic ocular topical medication Use topical systemic ocular medication study period History complication , adverse event , trauma disease nasolacrimal area History symptomatic epiphoria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>